Dr. Sydney Nykiel-Bailey has been appointed Director of the Anesthesiology Residency Program.
Nykiel-Bailey appointed Residency Program Director
Department of
Dr. Sydney Nykiel-Bailey has been appointed Director of the Anesthesiology Residency Program.
The American Society of Anesthesiologists (ASA) and the Society for Education in Anesthesia (SEA) have selected Rachel Moquin, EdD, as a 2025 recipient of the ASA-SEA Distinguished Educator in Anesthesiology Award.
Brian Torres, DNP, CRNA, has been appointed program director of the Nurse Anesthesia Program at Barnes-Jewish College Goldfarb School of Nursing. In addition, he will serve as director of CRNA education in the Department of Anesthesiology at WashU Medicine.
Mitsukuni Yoshida, MD, PhD, receives NIH Outstanding Scholars in Neuroscience Award for research on aging and disease.
As the academic year ends, we celebrate our graduating residents and fellows for their lasting impact on patient care, education, and the future of medicine. Learn more about their achievements and celebrations.
Fourth-year anesthesiology resident Mitsukuni Yoshida, MD, PhD, was recently awarded a $75,000 Research Fellowship Grant from the Foundation for Anesthesia Education and Research (FAER).
As graduation day approaches, our three chief residents reflect on their experiences, share what’s next in their careers, and offer advice to those following in their footsteps.
Residents from the Department of Anesthesiology at WashU Medicine presented their research and case reports at the 2025 Midwest Anesthesia Resident Conference (MARC), held April 25–27 in Indianapolis.
The Office of Postdoctoral Affairs at WashU Medicine has selected Burel Goodin, PhD, professor of anesthesiology, as the recipient of the 2025 Outstanding Faculty Mentor Award.
Roberta Teixeira Tallarico, MB, a first-year anesthesiology resident, recently had her T32 Research Fellowship project published in JAMA Surgery on April 30, 2025. Her study, “Postoperative Outcomes Among Sodium-Glucose Cotransporter 2 Inhibitor Users,” explores how a newer type of medication, called sodium-glucose cotransporter 2 inhibitors (SGLT2i), may influence surgical recovery.